“At Bioherent, we believe the future of biomedical innovation depends on our ability to measure and understand biological processes in real time. That’s why we develop photonic biosensors that bring continuous, high-quality data into complex biological workflows. 

In this project, we apply our BioXPLORER technology to bioreactors, enabling non-invasive and semi-continuous monitoring of key biomarkers during cell culture. This transforms traditional end-point testing into real-time, data-driven quality control, making regenerative implant validation faster, more predictive, and less reliant on destructive assays or animal testing.” 

Antonio Conde-González (Project Manager) holds a PhD in Chemistry from the University of Edinburgh and works at Bioherent as an Innovation Specialist.

Fotocredits: Bioherent